174 related articles for article (PubMed ID: 8724071)
1. Rapid oral desensitization to trimethoprim-sulfamethoxazole in infants and children.
Palusci VJ; Kaul A; Lawrence RM; Haines KA; Kwittken PL
Pediatr Infect Dis J; 1996 May; 15(5):456-60. PubMed ID: 8724071
[TBL] [Abstract][Full Text] [Related]
2. Trimethoprim-sulfamethoxazole oral desensitization in hemophiliacs infected with human immunodeficiency virus with a history of hypersensitivity reactions.
Kletzel M; Beck S; Elser J; Shock N; Burks W
Am J Dis Child; 1991 Dec; 145(12):1428-9. PubMed ID: 1688295
[TBL] [Abstract][Full Text] [Related]
3. Successful oral desensitization to trimethoprim-sulfamethoxazole in acquired immune deficiency syndrome.
Kalanadhabhatta V; Muppidi D; Sahni H; Robles A; Kramer M
Ann Allergy Asthma Immunol; 1996 Nov; 77(5):394-400. PubMed ID: 8933778
[TBL] [Abstract][Full Text] [Related]
4. Trimethoprim-sulfamethoxazole (cotrimoxazole) desensitization in an HIV-infected 5-yr-old girl.
Gómez-Traseira C; Boyano-Martínez T; Escosa-García L; Pedrosa M; Martín-Muñoz F; Quirce S
Pediatr Allergy Immunol; 2015 May; 26(3):287-289. PubMed ID: 25692246
[No Abstract] [Full Text] [Related]
5. A life-threatening adverse reaction during trimethoprim-sulfamethoxazole desensitization in a previously hypersensitive patient infected with human immunodeficiency virus.
Caumes E; Guermonprez G; Winter C; Katlama C; Bricaire F
Clin Infect Dis; 1996 Dec; 23(6):1313-4. PubMed ID: 8953079
[No Abstract] [Full Text] [Related]
6. Desensitization to trimethoprim/sulfamethoxazole in HIV-infected patients.
Absar N; Daneshvar H; Beall G
J Allergy Clin Immunol; 1994 Jun; 93(6):1001-5. PubMed ID: 8006304
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of desensitization to trimethoprim-sulfamethoxazole in human immunodeficiency virus-infected patients.
Piketty C; Gilquin J; Kazatchkine MD
J Infect Dis; 1995 Aug; 172(2):611. PubMed ID: 7622921
[No Abstract] [Full Text] [Related]
8. Rapid oral desensitization to trimethoprim-sulfamethoxazole (TMP-SMZ): use in prophylaxis for Pneumocystis carinii pneumonia in patients with AIDS who were previously intolerant to TMP-SMZ.
Gluckstein D; Ruskin J
Clin Infect Dis; 1995 Apr; 20(4):849-53. PubMed ID: 7795084
[TBL] [Abstract][Full Text] [Related]
9. Management of adverse reactions to prophylactic trimethoprim-sulfamethoxazole in patients with human immunodeficiency virus infection.
Belchi-Hernandez J; Espinosa-Parra FJ
Ann Allergy Asthma Immunol; 1996 Apr; 76(4):355-8. PubMed ID: 8612118
[TBL] [Abstract][Full Text] [Related]
10. A 5-day course of oral desensitization to trimethoprim/sulfamethoxazole (T/S) in patients with human immunodeficiency virus type-1 infection who were previously intolerant to T/S.
Yoshizawa S; Yasuoka A; Kikuchi Y; Honda M; Gatanaga H; Tachikawa N; Hirabayashi Y; Oka S
Ann Allergy Asthma Immunol; 2000 Sep; 85(3):241-4. PubMed ID: 11030281
[TBL] [Abstract][Full Text] [Related]
11. Two-day oral desensitization to trimethoprim-sulfamethoxazole in HIV-infected patients.
Nguyen MT; Weiss PJ; Wallace MR
AIDS; 1995 Jun; 9(6):573-5. PubMed ID: 7662195
[TBL] [Abstract][Full Text] [Related]
12. A life-threatening adverse reaction during trimethoprim-sulfamethoxazole desensitization in a previously hypersensitive patient infected with human immunodeficiency virus.
Marsh BJ
Clin Infect Dis; 1997 Sep; 25(3):754-6. PubMed ID: 9314486
[No Abstract] [Full Text] [Related]
13. Cotrimoxazole for prophylaxis or treatment of opportunistic infections of HIV/AIDS in patients with previous history of hypersensitivity to cotrimoxazole.
Lin D; Li WK; Rieder MJ
Cochrane Database Syst Rev; 2007 Apr; (2):CD005646. PubMed ID: 17443608
[TBL] [Abstract][Full Text] [Related]
14. Clinical and laboratory markers of hypersensitivity to trimethoprim-sulfamethoxazole in patients with Pneumocystis carinii pneumonia and AIDS.
Carr A; Swanson C; Penny R; Cooper DA
J Infect Dis; 1993 Jan; 167(1):180-5. PubMed ID: 8380290
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of desensitization with sulfamethoxazole and trimethoprim in 48 previously hypersensitive patients infected with human immunodeficiency virus.
Caumes E; Guermonprez G; Lecomte C; Katlama C; Bricaire F
Arch Dermatol; 1997 Apr; 133(4):465-9. PubMed ID: 9126010
[TBL] [Abstract][Full Text] [Related]
16. Management of adverse reactions to trimethoprim-sulfamethoxazole in human immunodeficiency virus-infected patients.
Jung AC; Paauw DS
Arch Intern Med; 1994 Nov; 154(21):2402-6. PubMed ID: 7979835
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of rechallenge with low-dose trimethoprim-sulphamethoxazole in previously hypersensitive HIV-infected patients.
Carr A; Penny R; Cooper DA
AIDS; 1993 Jan; 7(1):65-71. PubMed ID: 8442919
[TBL] [Abstract][Full Text] [Related]
18. Successful desensitization to dapsone for Pneumocystis carinii prophylaxis in an HIV-positive patient.
Cook DE; Kossey JL
Ann Pharmacother; 1998 Dec; 32(12):1302-5. PubMed ID: 9876811
[TBL] [Abstract][Full Text] [Related]
19. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV.
Podzamczer D; Salazar A; Jiménez J; Consiglio E; Santín M; Casanova A; Rufí G; Gudiol F
Ann Intern Med; 1995 May; 122(10):755-61. PubMed ID: 7717598
[TBL] [Abstract][Full Text] [Related]
20. "Treating through" hypersensitivity to cotrimoxazole in children with HIV infection.
Kreuz W; Güngör T; Lotz C; Funk M; Kornhuber B
Lancet; 1990 Aug; 336(8713):508-9. PubMed ID: 1975015
[No Abstract] [Full Text] [Related]
[Next] [New Search]
